EUVIMEDEUVIMED entdecken
Open Access

Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years

José I Nolazco, Lisa I Iezzoni, Eugene C Chen, Elyse R Park, Wei Wang, Michael S Leapman, Khalid Y Alkhatib, Jeremy Y C Teoh, Alexander P Cole, Matthew Mossanen, Aaron H Lay, Stephen J Bartels und 3 weitere

JAMA Network Open · 10.08.2026 · 9 (8) · e2627708

DOI: 10.1001/jamanetworkopen.2026.27708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 10.08.2026. Verfasst von José I Nolazco und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Persons with Disabilities, Prostate-Specific Antigen, Early Detection of Cancer. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance People with disabilities experience persistent inequities in preventive care, yet contemporary, nationally representative data on prostate-specific antigen (PSA) testing disparities are limited.

Objective

To evaluate the association between disability status and self-reported PSA testing among US men aged 55 to 69 years. Design, Setting, and Participants This cross-sectional study used 2023 data from the Behavioral Risk Factor Surveillance System (BRFSS), a US population-based telephone survey. The analytic sample included 10 508 male respondents aged 55 to 69 years with complete PSA testing and disability data; analyses incorporated BRFSS survey weights to generate nationally representative estimates. Data were analyzed from October 2024 to May 2025. Exposures Any disability and disability types (mobility, cognitive, hearing, vision, self-care, independent living) measured using the standard 6-question sequence. Main Outcomes and Measures The main outcome was self-reported PSA testing, assessed using BRFSS PSA items. Survey-weighted logistic regression was used to estimate adjusted odds ratios (AORs), controlling for sociodemographic factors, insurance, comorbidities, and health behaviors, with multiple imputation for missing covariates.

Results

The weighted analytic sample represented 5 058 866 US men aged 55 to 69 years; 29.6% reported at least 1 disability. Overall, 62.7% (95% CI, 61.1%-64.3%) reported prior PSA testing, with lower testing among men with disabilities than among those without (57.2% [95% CI, 54.2%-60.2%] vs 65.1% [95% CI, 63.2%-67.0%]; P < .001). In adjusted survey-weighted models, disability was associated with lower odds of PSA testing (AOR, 0.83; 95% CI, 0.69-0.99). Among disability types, mobility disability was associated with lower testing (AOR, 0.77; 95% CI, 0.62-0.96). In an unweighted sensitivity analysis, the association between any disability and lower PSA testing remained significant (AOR, 0.86; 95% CI, 0.77-0.98). Conclusions and Relevance In this nationally representative cross-sectional study of US men aged 55 to 69 years, disability status was associated with lower PSA testing, with the most consistent disparity observed among men with mobility disability. These findings suggest disability, particularly mobility impairment, may be an under-recognized determinant of preventive care and may warrant targeted interventions to improve equitable access to shared decision-making and screening services.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPersons with DisabilitiesProstate-Specific AntigenEarly Detection of CancerHumansMaleMiddle AgedCross-Sectional StudiesAgedUnited StatesBehavioral Risk Factor Surveillance SystemMen's Health Services

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
  • Servicio de Urología, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston.
  • Medical School, Medical College of Wisconsin, Milwaukee.
  • Department of Psychiatry, Massachusetts General Hospital, Boston.

Zitieren

APA

Nolazco, J. I., Iezzoni, L. I., Chen, E. C., Park, E. R., Wang, W., Leapman, M. S., Alkhatib, K. Y., Teoh, J. Y. C., Cole, A. P., Mossanen, M., Lay, A. H., Bartels, S. J., Kibel, A. S., Feldman, A. S., & Chang, S. L. (2026). Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years. JAMA Network Open, 9(8), e2627708. https://doi.org/10.1001/jamanetworkopen.2026.27708

Vancouver

Nolazco JI, Iezzoni LI, Chen EC, Park ER, Wang W, Leapman MS, et al. Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years. JAMA Network Open. 2026;9(8):e2627708. doi:10.1001/jamanetworkopen.2026.27708

BibTeX
@article{Nolazco2026,
  author = {Nolazco, José I and Iezzoni, Lisa I and Chen, Eugene C and Park, Elyse R and Wang, Wei and Leapman, Michael S and Alkhatib, Khalid Y and Teoh, Jeremy Y C and Cole, Alexander P and Mossanen, Matthew and Lay, Aaron H and Bartels, Stephen J and Kibel, Adam S and Feldman, Adam S and Chang, Steven L},
  title = {Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {8},
  pages = {e2627708},
  doi = {10.1001/jamanetworkopen.2026.27708}
}
Kostenlos starten →